Summit Therapeutics
SMMT
#1858
Rank
โ‚น1.046 T
Marketcap
โ‚น1,405
Share price
-1.47%
Change (1 day)
-10.90%
Change (1 year)

Market capitalization of Summit Therapeutics (SMMT)

Market cap: โ‚น1.046 Trillion

As of February 2026 Summit Therapeutics has a market cap of โ‚น1.046 Trillion. This makes Summit Therapeutics the world's 1858th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Summit Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น1.046 T-13.71%
2025โ‚น1.212 T5.23%
2024โ‚น1.152 T656.52%
2023โ‚น152.27 B115.08%
2022โ‚น70.80 B261.89%
2021โ‚น19.56 B-30.81%
2020โ‚น28.27 B268.89%
2019โ‚น7.66 B479.35%
2018โ‚น1.32 B-87.47%
2017โ‚น10.55 B47.62%
2016โ‚น7.15 B-23.64%
2015โ‚น9.36 B

End of Day market cap according to different sources

On Feb 25th, 2026 the market cap of Summit Therapeutics was reported to be:

โ‚น1.105 Trillion
by Nasdaq info icon info icon
โ‚น1.061 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
โ‚น161.11 B-84.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
โ‚น20.34 B-98.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
โ‚น22.48 B-97.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
โ‚น560.73 B-46.40%๐Ÿ‡บ๐Ÿ‡ธ USA